TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12294104
log Bayes Factor = 0.43523
Chromosome 11   position 30,382,899  (GRCh37) Explore rs12294104 on Ensembl!
Variant rs12294104 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N92.0 Excessive and frequent menstruation with regular cycle
0.000 0.514 0.486
N92 Excessive, frequent and irregular menstruation
0.000 0.864 0.136
N92.1 Excessive and frequent menstruation with irregular cycle
0.000 0.867 0.133
E11.9 Without complications
0.000 0.881 0.119
N84.1 Polyp of cervix uteri
0.114 0.885 0.000
N80.1 Endometriosis of ovary
0.000 0.890 0.110
N80 Endometriosis
0.000 0.893 0.107
N80.9 Endometriosis, unspecified
0.000 0.897 0.103
N92.2 Excessive menstruation at puberty
0.000 0.902 0.098
N80.2 Endometriosis of Fallopian tube
0.000 0.906 0.094
N80.8 Other endometriosis
0.000 0.907 0.093
N80.0 Endometriosis of uterus
0.000 0.915 0.085
N80.3 Endometriosis of pelvic peritoneum
0.000 0.917 0.083
N92.6 Irregular menstruation, unspecified
0.000 0.922 0.078
N80.6 Endometriosis in cutaneous scar
0.000 0.923 0.077
N92.4 Excessive bleeding in the premenopausal period
0.000 0.925 0.075
N80.5 Endometriosis of intestine
0.000 0.928 0.072
E11.5 With peripheral circulatory complications
0.000 0.931 0.069
E11 Non-insulin-dependent diabetes mellitus
0.000 0.932 0.068
N80.4 Endometriosis of rectovaginal septum and vagina
0.000 0.935 0.065
I12.0 Hypertensive renal disease with renal failure
0.000 0.939 0.061
N92.5 Other specified irregular menstruation
0.000 0.949 0.051
I12 Hypertensive renal disease
0.000 0.950 0.050
E11.8 With unspecified complications
0.000 0.951 0.049
E11.7 With multiple complications
0.000 0.951 0.049
E11.2 With renal complications
0.000 0.954 0.046
E11.6 With other specified complications
0.000 0.957 0.043
I10-I15 Hypertensive diseases
0.000 0.958 0.042
E11.4 With neurological complications
0.000 0.959 0.041
I10 Essential (primary) hypertension
0.000 0.960 0.040
E11.0 With coma
0.000 0.961 0.039
I12.9 Hypertensive renal disease without renal failure
0.000 0.964 0.036
E11.1 With ketoacidosis
0.000 0.966 0.034
I11 Hypertensive heart disease
0.000 0.966 0.034
I15 Secondary hypertension
0.000 0.968 0.032
I13 Hypertensive heart and renal disease
0.000 0.969 0.030
E10-E14 Diabetes mellitus
0.000 0.971 0.029
G40.9 Epilepsy, unspecified
0.000 0.973 0.027
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.973 0.027
E10 Insulin-dependent diabetes mellitus
0.000 0.974 0.026
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.974 0.026
I15.1 Hypertension secondary to other renal disorders
0.000 0.974 0.026
E10.9 Without complications
0.000 0.975 0.025
I15.8 Other secondary hypertension
0.000 0.977 0.023
I15.2 Hypertension secondary to endocrine disorders
0.000 0.977 0.023
I15.0 Renovascular hypertension
0.000 0.977 0.023
I15.9 Seconday hypertension, unspecified
0.000 0.977 0.022
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.978 0.022
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.978 0.022
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.978 0.022
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.978 0.022
E10.8 With unspecified complications
0.000 0.978 0.022
E12 Malnutrition-related diabetes mellitus
0.000 0.979 0.021
E10.0 With coma
0.000 0.979 0.021
E13 Other specified diabetes mellitus
0.000 0.980 0.020
E10.2 With renal complications
0.000 0.980 0.020
E11.3 With ophthalmic complications
0.000 0.980 0.019
E10.7 With multiple complications
0.000 0.981 0.019
G40 Epilepsy
0.000 0.981 0.019
E10.4 With neurological complications
0.000 0.981 0.019
E10.6 With other specified complications
0.000 0.982 0.018
G40.8 Other epilepsy
0.000 0.983 0.017
E10.5 With peripheral circulatory complications
0.000 0.984 0.016
N83.0 Follicular cyst of ovary
0.000 0.984 0.016
G40.3 Generalised idiopathic epilepsy and epileptic syndromes
0.000 0.984 0.016
E10.3 With ophthalmic complications
0.000 0.984 0.016
G40.6 Grand mal seizures, unspecified (with or without petit mal)
0.000 0.984 0.016
E10.1 With ketoacidosis
0.000 0.984 0.016
E12.9 Without complications
0.000 0.984 0.015
E12.8 With unspecified complications
0.000 0.984 0.015
E12.7 With multiple complications
0.000 0.984 0.015
E12.6 With other specified complications
0.000 0.984 0.015
E12.5 With peripheral circulatory complications
0.000 0.984 0.015
E12.4 With neurological complications
0.000 0.984 0.015
E12.3 With ophthalmic complications
0.000 0.984 0.015
E12.2 With renal complications
0.000 0.984 0.015
E12.1 With ketoacidosis
0.000 0.984 0.015
E12.0 With coma
0.000 0.984 0.015
N80-N98 Noninflammatory disorders of female genital tract
0.000 0.985 0.015
E13.8 With unspecified complications
0.000 0.985 0.014
E13.7 With multiple complications
0.000 0.985 0.014
E13.6 With other specified complications
0.000 0.985 0.014
E13.5 With peripheral circulatory complications
0.000 0.985 0.014
E13.4 With neurological complications
0.000 0.985 0.014
E13.2 With renal complications
0.000 0.985 0.014
E13.1 With ketoacidosis
0.000 0.985 0.014
E13.0 With coma
0.000 0.985 0.014
E13.9 Without complications
0.000 0.986 0.014
G40.5 Special epileptic syndromes
0.000 0.986 0.014
G40.4 Other generalised epilepsy and epileptic syndromes
0.000 0.986 0.014
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset
0.000 0.986 0.014
E13.3 With ophthalmic complications
0.000 0.987 0.013
N97 Female infertility
0.000 0.987 0.013
G40.7 Petit mal, unspecified, without grand mal seizures
0.000 0.987 0.013
N86 Erosion and ectropion of cervix uteri
0.000 0.987 0.013
E14 Unspecified diabetes mellitus
0.000 0.988 0.012
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.012 0.988 0.000
N92.3 Ovulation bleeding
0.000 0.988 0.012
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.000 0.988 0.012
N97.9 Female infertility, unspecified
0.000 0.989 0.011
N91 Absent, scanty and rare menstruation
0.000 0.989 0.011
N84 Polyp of female genital tract
0.004 0.989 0.008
N96 Habitual aborter
0.000 0.989 0.011
N97.1 Female infertility of tubal origin
0.000 0.989 0.010
N98 Complications associated with artificial fertilisation
0.000 0.990 0.010
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.000 0.990 0.010
G37.9 Demyelinating disease of central nervous system, unspecified
0.010 0.990 0.000
N91.2 Amenorrhoea, unspecified
0.000 0.990 0.010
N97.8 Female infertility of other origin
0.000 0.990 0.010
N97.4 Female infertility associated with male factors
0.000 0.990 0.010
N97.3 Female infertility of cervical origin
0.000 0.990 0.010
N97.2 Female infertility of uterine origin
0.000 0.990 0.010
N97.0 Female infertility associated with anovulation
0.000 0.990 0.010
N82 Fistulae involving female genital tract
0.000 0.991 0.009
D22.5 Melanocytic naevi of trunk
0.000 0.991 0.009
N89 Other noninflammatory disorders of vagina
0.000 0.991 0.009
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube
0.000 0.991 0.009
E14.8 With unspecified complications
0.000 0.991 0.009
E14.7 With multiple complications
0.000 0.991 0.009
E14.6 With other specified complications
0.000 0.991 0.009
E14.2 Withrenal complications
0.000 0.991 0.009
E14.0 With coma
0.000 0.991 0.009
E14.1 With ketoacidosis
0.000 0.991 0.009
N83.7 Haematoma of broad ligament
0.000 0.991 0.009
N83.6 Haematosalpinx
0.000 0.991 0.009
N83.4 Prolapse and hernia of ovary and Fallopian tube
0.000 0.991 0.009
M06.9 Rheumatoid arthritis, unspecified
0.009 0.991 0.000
N83.1 Corpus luteum cyst
0.000 0.991 0.009
N91.5 Oligomenorrhoea, unspecified
0.000 0.991 0.008
E14.5 With peripheral circulatory complications
0.000 0.991 0.008
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
0.000 0.991 0.008
N84.9 Polyp of female genital tract, unspecified
0.002 0.992 0.006
N91.4 Secondary oligomenorrhoea
0.000 0.992 0.008
N91.3 Primary oligomenorrhoea
0.000 0.992 0.008
N91.0 Primary amenorrhoea
0.000 0.992 0.008
E14.3 With ophthalmic complications
0.000 0.992 0.008
E14.4 With neurological complications
0.000 0.992 0.008
N84.2 Polyp of vagina
0.001 0.992 0.007
N84.3 Polyp of vulva
0.002 0.992 0.006
N84.8 Polyp of other parts of female genital tract
0.003 0.992 0.005
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.008 0.992 0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.008 0.992 0.000
N89.5 Stricture and atresia of vagina
0.000 0.992 0.008
N98.9 Complication associated with artificial fertilisation, unspecified
0.000 0.992 0.007
N98.8 Other complications associated with artificial fertilisation
0.000 0.992 0.007
N98.3 Complications of attempted introduction of embryo in embryo transfer
0.000 0.992 0.007
N98.2 Complications of attempted introduction of fertilised ovum following in vitro fertilisation
0.000 0.992 0.007
N98.0 Infection associated with artificial insemination
0.000 0.992 0.007
Y85.0 Sequelae of motor-vehicle accident
0.008 0.992 0.000
N89.6 Tight hymenal ring
0.000 0.992 0.007
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified
0.000 0.993 0.007
N98.1 Hyperstimulation of ovaries
0.000 0.993 0.007
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.007 0.993 0.000
N82.0 Vesicovaginal fistula
0.000 0.993 0.007
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.007 0.993 0.000
H35.0 Background retinopathy and retinal vascular changes
0.000 0.993 0.007
N82.8 Other female genital tract fistulae
0.000 0.993 0.007
N82.5 Female genital tract-skin fistulae
0.000 0.993 0.007
N82.2 Fistula of vagina to small intestine
0.000 0.993 0.007
N82.1 Other female urinary-genital tract fistulae
0.000 0.993 0.007
N91.1 Secondary amenorrhoea
0.000 0.993 0.007
N89.7 Haematocolpos
0.000 0.993 0.007
N89.4 Leukoplakia of vagina
0.000 0.993 0.007
N89.3 Dysplasia of vagina, unspecified
0.000 0.993 0.007
N89.2 Severe vaginal dysplasia, not elsewhere classified
0.000 0.993 0.007
N89.1 Moderate vaginal dysplasia
0.000 0.993 0.007
N89.0 Mild vaginal dysplasia
0.000 0.993 0.007
M06.98 Rheumatoid arthritis, unspecified (Other)
0.007 0.993 0.000
L43.9 Lichen planus, unspecified
0.000 0.993 0.007
N82.9 Female genital tract fistula, unspecified
0.000 0.993 0.006
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.007 0.993 0.000
G45 Transient cerebral ischaemic attacks and related syndromes
0.000 0.993 0.006
G45.3 Amaurosis fugax
0.000 0.994 0.006
G40-G47 Episodic and paroxysmal disorders
0.000 0.994 0.006
N82.3 Fistula of vagina to large intestine
0.000 0.994 0.006
N82.4 Other female intestinal-genital tract fistulae
0.000 0.994 0.006
N83.3 Acquired atrophy of ovary and Fallopian tube
0.000 0.994 0.006
G45.8 Other transient cerebral ischaemic attacks and related syndromes
0.000 0.994 0.006
N87 Dysplasia of cervix uteri
0.000 0.994 0.006
N89.9 Noninflammatory disorder of vagina, unspecified
0.000 0.994 0.006
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.006 0.994 0.000
R07.3 Other chest pain
0.000 0.994 0.006
H33.2 Serous retinal detachment
0.000 0.995 0.005
H35.8 Other specified retinal disorders
0.000 0.995 0.005
M06 Other rheumatoid arthritis
0.005 0.995 0.000
G45.0 Vertebro-basilar artery syndrome
0.000 0.995 0.005
G46 Vascular syndromes of brain in cerebrovascular diseases
0.000 0.995 0.005
G45.2 Multiple and bilateral precerebral artery syndromes
0.000 0.995 0.005
G45.1 Carotid artery syndrome (hemispheric)
0.000 0.995 0.005
G43 Migraine
0.000 0.995 0.005
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.005 0.995 0.000
H35 Other retinal disorders
0.000 0.995 0.005
N87.1 Moderate cervical dysplasia
0.000 0.995 0.005
H18.8 Other specified disorders of cornea
0.000 0.995 0.005
G45.9 Transient cerebral ischaemic attack, unspecified
0.000 0.995 0.005
M06.4 Inflammatory polyarthropathy
0.005 0.995 0.000
J03.9 Acute tonsillitis, unspecified
0.005 0.995 0.000
N87.2 Severe cervical dysplasia, not elsewhere classified
0.000 0.995 0.005
G41 Status epilepticus
0.000 0.995 0.004
L43 Lichen planus
0.000 0.996 0.004
S82.50 Fracture of medial malleolus (closed)
0.004 0.996 0.000
H35.7 Separation of retinal layers
0.000 0.996 0.004
G43.1 Migraine with aura [classical migraine]
0.000 0.996 0.004
G82.1 Spastic paraplegia
0.004 0.996 0.000
M06.0 Seronegative rheumatoid arthritis
0.004 0.996 0.000
M06.8 Other specified rheumatoid arthritis
0.004 0.996 0.000
M06.2 Rheumatoid bursitis
0.004 0.996 0.000
M06.1 Adult-onset Still's disease
0.004 0.996 0.000
O02.1 Missed abortion
0.004 0.996 0.000
C77.9 Lymph node, unspecified
0.000 0.996 0.004
G46.4 Cerebellar stroke syndrome
0.000 0.996 0.004
M06.3 Rheumatoid nodule
0.004 0.996 0.000
Z34.8 Supervision of other normal pregnancy
0.000 0.996 0.004
G82 Paraplegia and tetraplegia
0.004 0.996 0.000
H35.2 Other proliferative retinopathy
0.000 0.996 0.004
M06.04 Seronegative rheumatoid arthritis (Hand)
0.004 0.996 0.000
G46.8 Other vascular syndromes of brain in cerebrovascular diseases
0.000 0.996 0.004
G46.6 Pure sensory lacunar syndrome
0.000 0.996 0.004
G46.5 Pure motor lacunar syndrome
0.000 0.996 0.004
G46.3 Brain stem stroke syndrome
0.000 0.996 0.004
G46.2 Posterior cerebral artery syndrome
0.000 0.996 0.004
G46.1 Anterior cerebral artery syndrome
0.000 0.996 0.004
G46.0 Middle cerebral artery syndrome
0.000 0.996 0.004
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.004 0.996 0.000
G46.7 Other lacunar syndromes
0.000 0.996 0.004
G82.2 Paraplegia, unspecified
0.004 0.996 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.004 0.996 0.000
R22.4 Localised swelling, mass and lump, lower limb
0.000 0.996 0.004
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.004 0.996 0.000
G37 Other demyelinating diseases of central nervous system
0.004 0.996 0.000
G43.3 Complicated migraine
0.000 0.996 0.004
G43.2 Status migrainosus
0.000 0.996 0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.004 0.996 0.000
G82.4 Spastic tetraplegia
0.004 0.996 0.000
H35.1 Retinopathy of prematurity
0.000 0.996 0.004
H18 Other disorders of cornea
0.000 0.996 0.004
L43.8 Other lichen planus
0.000 0.996 0.004
G44 Other headache syndromes
0.000 0.996 0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.004 0.996 0.000
H18.6 Keratoconus
0.000 0.996 0.004
T50.9 Other and unspecified drugs, medicaments and biological substances
0.004 0.996 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.004 0.996 0.000
N88 Other noninflammatory disorders of cervix uteri
0.000 0.996 0.004
E61.1 Iron deficiency
0.000 0.996 0.004
H35.4 Peripheral retinal degeneration
0.000 0.996 0.004
R52.9 Pain, unspecified
0.000 0.996 0.004
G41.0 Grand mal status epilepticus
0.000 0.996 0.003
M06.48 Inflammatory polyarthropathy (Other)
0.003 0.996 0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.003 0.996 0.000
M06.46 Inflammatory polyarthropathy (Lower leg)
0.003 0.996 0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.003 0.996 0.000
M06.44 Inflammatory polyarthropathy (Hand)
0.003 0.996 0.000
M06.43 Inflammatory polyarthropathy (Forearm)
0.003 0.996 0.000
M06.42 Inflammatory polyarthropathy (Upper arm)
0.003 0.996 0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.003 0.996 0.000
H35.9 Retinal disorder, unspecified
0.000 0.996 0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.004 0.996 0.000
Y85 Sequelae of transport accidents
0.004 0.996 0.000
G41.8 Other status epilepticus
0.000 0.996 0.003
G41.2 Complex partial status epilepticus
0.000 0.996 0.003
G41.1 Petit mal status epilepticus
0.000 0.996 0.003
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.000 0.996 0.003
H35.5 Hereditary retinal dystrophy
0.000 0.996 0.003
E14.9 Without complications
0.000 0.996 0.004
G43.0 Migraine without aura [common migraine]
0.000 0.996 0.003
T46.1 Calcium-channel blockers
0.003 0.996 0.000
L43.3 Subacute (active) lichen planus
0.000 0.997 0.003
L43.2 Lichenoid drug reaction
0.000 0.997 0.003
L43.1 Bullous lichen planus
0.000 0.997 0.003
L43.0 Hypertrophic lichen planus
0.000 0.997 0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.003 0.997 0.000
G43.9 Migraine, unspecified
0.000 0.997 0.003
H18.9 Disorder of cornea, unspecified
0.000 0.997 0.003
L08.9 Local infection of skin and subcutaneous tissue, unspecified
0.003 0.997 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.003 0.997 0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.003 0.997 0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.003 0.997 0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.003 0.997 0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.003 0.997 0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.003 0.997 0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.003 0.997 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.003 0.997 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.003 0.997 0.000
H18.4 Corneal degeneration
0.000 0.997 0.003
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm
0.000 0.997 0.003
G43.8 Other migraine
0.000 0.997 0.003
T36-T50 Poisoning by drugs, medicaments and biological substances
0.003 0.997 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.003 0.997 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.003 0.997 0.000
M06.32 Rheumatoid nodule (Upper arm)
0.003 0.997 0.000
M06.19 Adult-onset Still's disease (Site unspecified)
0.003 0.997 0.000
M06.18 Adult-onset Still's disease (Other)
0.003 0.997 0.000
M06.17 Adult-onset Still's disease (Ankle and foot)
0.003 0.997 0.000
M06.16 Adult-onset Still's disease (Lower leg)
0.003 0.997 0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.003 0.997 0.000
M06.14 Adult-onset Still's disease (Hand)
0.003 0.997 0.000
M06.13 Adult-onset Still's disease (Forearm)
0.003 0.997 0.000
M06.12 Adult-onset Still's disease (Upper arm)
0.003 0.997 0.000
M06.11 Adult-onset Still's disease (Shoulder region)
0.003 0.997 0.000
M06.10 Adult-onset Still's disease (Multiple sites)
0.003 0.997 0.000
M06.29 Rheumatoid bursitis (Site unspecified)
0.003 0.997 0.000
M06.28 Rheumatoid bursitis (Other)
0.003 0.997 0.000
M06.27 Rheumatoid bursitis (Ankle and foot)
0.003 0.997 0.000
M06.26 Rheumatoid bursitis (Lower leg)
0.003 0.997 0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.003 0.997 0.000
M06.24 Rheumatoid bursitis (Hand)
0.003 0.997 0.000
M06.23 Rheumatoid bursitis (Forearm)
0.003 0.997 0.000
M06.22 Rheumatoid bursitis (Upper arm)
0.003 0.997 0.000
M06.21 Rheumatoid bursitis (Shoulder region)
0.003 0.997 0.000
M06.20 Rheumatoid bursitis (Multiple sites)
0.003 0.997 0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.003 0.997 0.000
M06.88 Other specified rheumatoid arthritis (Other)
0.003 0.997 0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.003 0.997 0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.003 0.997 0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.003 0.997 0.000
M06.84 Other specified rheumatoid arthritis (Hand)
0.003 0.997 0.000
M06.83 Other specified rheumatoid arthritis (Forearm)
0.003 0.997 0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.003 0.997 0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.003 0.997 0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.003 0.997 0.000
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)
0.003 0.997 0.000
Z13.1 Special screening examination for diabetes mellitus
0.000 0.997 0.003
G44.4 Drug-induced headache, not elsewhere classified
0.000 0.997 0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.003 0.997 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.003 0.997 0.000
G45.4 Transient global amnesia
0.000 0.997 0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.003 0.997 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.003 0.997 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.003 0.997 0.000
M06.39 Rheumatoid nodule (Site unspecified)
0.003 0.997 0.000
M06.38 Rheumatoid nodule (Other)
0.003 0.997 0.000
M06.36 Rheumatoid nodule (Lower leg)
0.003 0.997 0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.003 0.997 0.000
M06.33 Rheumatoid nodule (Forearm)
0.003 0.997 0.000
M06.31 Rheumatoid nodule (Shoulder region)
0.003 0.997 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.003 0.997 0.000
T45.2 Vitamins, not elsewhere classified
0.003 0.997 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.003 0.997 0.000
G82.3 Flaccid tetraplegia
0.003 0.997 0.000
G82.0 Flaccid paraplegia
0.003 0.997 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.003 0.997 0.000
M06.37 Rheumatoid nodule (Ankle and foot)
0.003 0.997 0.000
G82.5 Tetraplegia, unspecified
0.003 0.997 0.000
H73.8 Other specified disorders of tympanic membrane
0.000 0.997 0.003
T50.4 Drugs affecting uric acid metabolism
0.003 0.997 0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.003 0.997 0.000
G41.9 Status epilepticus, unspecified
0.000 0.997 0.003
H18.2 Other corneal oedema
0.000 0.997 0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.003 0.997 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.003 0.997 0.000
T46.7 Peripheral vasodilators
0.003 0.997 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.003 0.997 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.003 0.997 0.000
G37.5 Concentric sclerosis [Balo]
0.003 0.997 0.000
G37.4 Subacute necrotising myelitis
0.003 0.997 0.000
G37.2 Central pontine myelinolysis
0.003 0.997 0.000
G37.1 Central demyelination of corpus callosum
0.003 0.997 0.000
G37.0 Diffuse sclerosis
0.003 0.997 0.000
H18.7 Other corneal deformities
0.000 0.997 0.003
H18.3 Changes in corneal membranes
0.000 0.997 0.003
H18.0 Corneal pigmentations and deposits
0.000 0.997 0.003
G44.1 Vascular headache, not elsewhere classified
0.000 0.997 0.003
N83.2 Other and unspecified ovarian cysts
0.000 0.997 0.003
T50.8 Diagnostic agents
0.003 0.997 0.000
T50.7 Analeptics and opioid receptor antagonists
0.003 0.997 0.000
T50.5 Appetite depressants
0.003 0.997 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
T50.1 Loop [high-ceiling] diuretics
0.003 0.997 0.000
T50.0 Mineralocorticoids and their antagonists
0.003 0.997 0.000
H18.1 Bullous keratopathy
0.000 0.997 0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.003 0.997 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.003 0.997 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.003 0.997 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.003 0.997 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.003 0.997 0.000
T44.0 Anticholinesterase agents
0.003 0.997 0.000
N88.4 Hypertrophic elongation of cervix uteri
0.000 0.997 0.003
N88.3 Incompetence of cervix uteri
0.000 0.997 0.003
N88.0 Leukoplakia of cervix uteri
0.000 0.997 0.003
X63.0 Home
0.003 0.997 0.000
J04.0 Acute laryngitis
0.003 0.997 0.000
F00.9 Dementia in Alzheimer's disease, unspecified
0.000 0.997 0.003
T45.1 Antineoplastic and immunosuppressive drugs
0.003 0.997 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.003 0.997 0.000
H35.6 Retinal haemorrhage
0.000 0.997 0.003
Z13.6 Special screening examination for cardiovascular disorders
0.000 0.997 0.003
G44.8 Other specified headache syndromes
0.000 0.997 0.003
G44.0 Cluster headache syndrome
0.000 0.997 0.003
M16.0 Primary coxarthrosis, bilateral
0.000 0.997 0.003
N88.1 Old laceration of cervix uteri
0.000 0.997 0.003
G37.8 Other specified demyelinating diseases of central nervous system
0.003 0.997 0.000
E78.5 Hyperlipidaemia, unspecified
0.000 0.997 0.003
G44.3 Chronic posttraumatic headache
0.000 0.997 0.003
M06.34 Rheumatoid nodule (Hand)
0.002 0.997 0.000
K25.7 Chronic without haemorrhage or perforation
0.000 0.997 0.003
N87.0 Mild cervical dysplasia
0.000 0.997 0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.003 0.997 0.000
Q50.4 Embryonic cyst of Fallopian tube
0.000 0.997 0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.003 0.997 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.003 0.997 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.003 0.997 0.000
T38.9 Other and unspecified hormone antagonists
0.002 0.997 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.997 0.000
T38.7 Androgens and anabolic congeners
0.002 0.997 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.002 0.997 0.000
T38.5 Other oestrogens and progestogens
0.002 0.997 0.000
T38.4 Oral contraceptives
0.002 0.997 0.000
T38.2 Antithyroid drugs
0.002 0.997 0.000
T38.0 Glucocorticoids and synthetic analogues
0.002 0.997 0.000
F01.9 Vascular dementia, unspecified
0.000 0.997 0.003
L40.0 Psoriasis vulgaris
0.000 0.997 0.003
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)
0.003 0.997 0.000
Y85.9 Sequelae of other and unspecified transport accidents
0.003 0.997 0.000
J03 Acute tonsillitis
0.003 0.997 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.002 0.997 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.002 0.997 0.000
T47.7 Emetics
0.002 0.997 0.000
T47.6 Antidiarrhoeal drugs
0.002 0.997 0.000
T47.5 Digestants
0.002 0.997 0.000
T47.4 Other laxatives
0.002 0.997 0.000
T47.3 Saline and osmotic laxatives
0.002 0.997 0.000
T47.2 Stimulant laxatives
0.002 0.997 0.000
T47.0 Histamine H(2)-receptor antagonists
0.002 0.997 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.002 0.997 0.000
T45.8 Other primarily systemic and haematological agents
0.002 0.997 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.997 0.000
T45.6 Fibrinolysis-affecting drugs
0.002 0.997 0.000
T45.4 Iron and its compounds
0.002 0.997 0.000
T45.3 Enzymes, not elsewhere classified
0.002 0.997 0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)
0.003 0.997 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.002 0.997 0.000
H04.2 Epiphora
0.003 0.997 0.000
T45.0 Antiallergic and antiemetic drugs
0.002 0.997 0.000
J18.0 Bronchopneumonia, unspecified
0.000 0.997 0.002
N88.9 Noninflammatory disorder of cervix uteri, unspecified
0.000 0.997 0.002
L40 Psoriasis
0.000 0.998 0.002
S32.40 Fracture of acetabulum (closed)
0.002 0.998 0.000
H04.9 Disorder of lachrymal system, unspecified
0.002 0.998 0.000
T38.1 Thyroid hormones and substitutes
0.002 0.998 0.000
M93.9 Osteochondropathy, unspecified
0.002 0.998 0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.002 0.998 0.000
X62.9 Unspecified place
0.002 0.998 0.000
E61 Deficiency of other nutrient elements
0.000 0.998 0.002
S61.1 Open wound of finger(s) with damage to nail
0.000 0.998 0.002
T40.4 Other synthetic narcotics
0.002 0.998 0.000
L40-L45 Papulosquamous disorders
0.000 0.998 0.002
L89.2 Stage III decubitus ulcer
0.000 0.998 0.002
L89.1 Stage II decubitus ulcer
0.000 0.998 0.002
N89.8 Other specified noninflammatory disorders of vagina
0.000 0.998 0.002
M19.1 Posttraumatic arthrosis of other joints
0.002 0.998 0.000
R07.2 Precordial pain
0.000 0.998 0.002
T40.2 Other opioids
0.002 0.998 0.000
T36 Poisoning by systemic antibiotics
0.002 0.998 0.000
N87.9 Dysplasia of cervix uteri, unspecified
0.000 0.998 0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.002 0.998 0.000
T40.8 Lysergide [LSD]
0.002 0.998 0.000
T40.7 Cannabis (derivatives)
0.002 0.998 0.000
T40.5 Cocaine
0.002 0.998 0.000
T40.3 Methadone
0.002 0.998 0.000
T40.1 Heroin
0.002 0.998 0.000
T40.0 Opium
0.002 0.998 0.000
F00 Dementia in Alzheimer's disease
0.000 0.998 0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system
0.002 0.998 0.000
S82.5 Fracture of medial malleolus
0.002 0.998 0.000
T40.6 Other and unspecified narcotics
0.002 0.998 0.000
T79.3 Post-traumatic wound infection, not elsewhere classified
0.002 0.998 0.000
T45.5 Anticoagulants
0.002 0.998 0.000
L89.3 Stage IV decubitus ulcer
0.000 0.998 0.002
R07.1 Chest pain on breathing
0.000 0.998 0.002
T79.7 Traumatic subcutaneous emphysema
0.002 0.998 0.000
R07 Pain in throat and chest
0.000 0.998 0.002
N50.8 Other specified disorders of male genital organs
0.000 0.998 0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.002 0.998 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.002 0.998 0.000
T37.5 Antiviral drugs
0.002 0.998 0.000
T37.4 Anthelminthics
0.002 0.998 0.000
T37.3 Other antiprotozoal drugs
0.002 0.998 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.002 0.998 0.000
T37.1 Antimycobacterial drugs
0.002 0.998 0.000
T37.0 Sulphonamides
0.002 0.998 0.000
T41.5 Therapeutic gases
0.002 0.998 0.000
T41.4 Anaesthetic, unspecified
0.002 0.998 0.000
T41.3 Local anaesthetics
0.002 0.998 0.000
T41.2 Other and unspecified general anaesthetics
0.002 0.998 0.000
T41.1 Intravenous anaesthetics
0.002 0.998 0.000
T41.0 Inhaled anaesthetics
0.002 0.998 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.998 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.002 0.998 0.000
T48.5 Anti-common-cold drugs
0.002 0.998 0.000
T48.4 Expectorants
0.002 0.998 0.000
T48.3 Antitussives
0.002 0.998 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.002 0.998 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.002 0.998 0.000
T48.0 Oxytocic drugs
0.002 0.998 0.000
T49.9 Topical agent, unspecified
0.002 0.998 0.000
T49.8 Other topical agents
0.002 0.998 0.000
T49.7 Dental drugs, topically applied
0.002 0.998 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.